Discover 3,073 paid clinical trials in Houston, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Houston is home to world-renowned medical centers offering a variety of trials targeting conditions such as cancer, heart disease, diabetes, and Alzheimer’s. Healthy volunteers interested in paid research opportunities, as well as individuals in need of trials for specific conditions, can participate in these studies to access cutting-edge treatments and contribute to the development of innovative therapies.
Filter
2
Filter results
Results: 3,073
Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma
Venetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid Leukemia
for
High Risk Myelodysplastic Syndrome,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT03214562
Phase1, Phase2, Recruiting
An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors
for
Breast Cancer, Advanced Solid Tumor
Location: Houston TX, Austin TX, Birmingham AL, St Louis MO,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT07222267
Phase1, Recruiting
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
for
Overweight, Obesity
Location: Houston TX, Austin TX, Corpus Christi TX,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07282600
Phase3, Recruiting
The Gut Microbiome and Immunotherapy Response in Solid Cancers
for
Cancer
Location: Galveston TX
Sponsor: The University of Texas Medical Branch, Galveston
Sex: All
Age: 35 - 70+
Code: NCT06050733
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Phase I/II Clinical Trial of Axatilimab, a CSF1R Monoclonal Antibody, in Combination With Ruxolitinib as Therapy for Patients With Myelofibrosis (MF) and Chronic Myelomonocytic Leukemia (CMML)
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
for
Breast Neoplasms, Neoplasm Metastasis
Location: Houston TX, Baytown TX, The Woodlands TX,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07174336
Phase3, Recruiting
Exploring the Benefit of Topical Capsaicin in Treating Pain From Chemo-induced Peripheral Neuropathy: a Longitudinal Single Center Pilot Study
for
Peripheral Neuropathy Due to Chemotherapy
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06744816
Early_phase1, Recruiting
Phase 2 EL219 Versus Liposomal Amphotericin B or Voriconazole for Early Antifungal Therapy
for
Invasive Mould Infection
Location: Houston TX, Birmingham AL, St Louis MO, Augusta GA,
Sponsor: Elion Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07215273
Phase2, Recruiting
A New Combination of Evidence-Based Interventions to Improve Primary Care Diagnostic Safety and Efficiency
for
Anemia, Decreased Glomerular Filtration Rate
Location: Houston TX
Sponsor: The University of Texas Health Science Center, Houston
Sex: All
Age: 18+
Code: NCT05735314
Recruiting
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
for
Carcinoma, Non-Small-Cell Lung,
Location: Houston TX, San Antonio TX, Dallas TX, Fort Worth TX,
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Sex: All
Age: 18+
Code: NCT05208762
Phase1, Recruiting
Phase II Study of Pembrolizumab in Combination With Lenvatinib in Patients With TNBC, NSCLC, and Other Tumor Types and Brain Metastases
for
Brain Metastases, Tumor
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT05064280
Phase2, Recruiting
A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies
for
Advanced Solid Tumors, Ewing Sarcoma,
Location: Houston TX, Newport Beach CA, Duarte CA, New York NY,
Sponsor: SEED Therapeutics, Inc.
Sex: All
Age: 16+
Code: NCT07197554
Phase1, Recruiting
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.
for
Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma,
Location: Houston TX, Dallas TX, Columbus OH, Canton OH,
Sponsor: OncoNano Medicine, Inc.
Sex: All
Age: 18+
Code: NCT06022029
Phase1, Recruiting
A Phase I Study of ROSE12 Alone and in Combination With Other Anti-tumor Agents in Patients With Solid Tumors
for
Solid Tumor
Location: Houston TX, Nashville TN, Fairfax VA, Philadelphia PA,
Sponsor: Chugai Pharmaceutical
Sex: All
Age: 18+
Code: NCT05907980
Phase1, Recruiting
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
for
Type 1 Diabetes
Location: Houston TX, San Antonio TX, Dallas TX, Fort Worth TX,
Sponsor: SAb Biotherapeutics, Inc.
Sex: All
Age: 5 - 40
Code: NCT07187531
Phase2, Recruiting
A Trial Evaluating the Efficacy of Ivonescimab in Metastatic Endocrine Refractory HR-positive HER2-negative or Triple Negative Invasive Lobular Carcinoma
for
Metastatic Endocrine Refractory,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT07229417
Phase2, Recruiting
Self-sampling to Optimize Anal Lesion Outcomes
for
Anal Cancer
Location: Houston TX, Chicago IL, Milwaukee WI
Sponsor: Medical College of Wisconsin
Sex: All
Age: 35+
Code: NCT07192055
Recruiting
A Study to Learn About Ritlecitinib for the Potential Treatment of Chronic Spontaneous Urticaria in Adults.
for
Chronic Spontaneous Urticaria
Location: Sugar Land TX, Austin TX, San Antonio TX,